THU0192 5-Year Results from the Rapid 1 Trial and Open-Label Extension: Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A228.2-A229 ◽  
Author(s):  
E. Keystone ◽  
R. Landewé ◽  
R. van Vollenhoven ◽  
B. Combe ◽  
V. Strand ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Certolizumab Pegol ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension

FRI0186 Long-term safety and efficacy of 4-weekly certolizumab pegol monotherapy and combination therapy in rheumatoid arthritis: 5-year results from an open-label extension study

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A435.1-A435 ◽  
Author(s):  
R. Fleischmann ◽  
R. van Vollenhoven ◽  
J. Vencovsky ◽  
R. Alten ◽  
O. Davies ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Combination Therapy ◽  
Certolizumab Pegol ◽  
Extension Study ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension

scholarly journals Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

2013 ◽  
Vol 73 (12) ◽  
pp. 2094-2100 ◽  
Author(s):  
Edward Keystone ◽  
Robert Landewé ◽  
Ronald van Vollenhoven ◽  
Bernard Combe ◽  
Vibeke Strand ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Certolizumab Pegol ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension

scholarly journals Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study

2013 ◽  
Vol 24 (5) ◽  
pp. 725-733 ◽  
Author(s):  
Yoshiya Tanaka ◽  
Kazuhiko Yamamoto ◽  
Tsutomu Takeuchi ◽  
Hisashi Yamanaka ◽  
Naoki Ishiguro ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Certolizumab Pegol ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis

2019 ◽  
Vol 21 (1) ◽  
Author(s):  
Stanley Cohen ◽  
Jose L. Pablos ◽  
Karel Pavelka ◽  
Gerard Anton Müller ◽  
Alan Matsumoto ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Extension Study ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension ◽  
Abp 501

scholarly journals THU0173 Long term safety and efficacy of filgotinib in a phase 2B open label extension study in patients with rheumatoid arthritis: results up to 144 weeks

2017 ◽  
Author(s):  
R Alten ◽  
R Westhovens ◽  
A Kavanaugh ◽  
M Genovese ◽  
K Winthrop ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Extension Study ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension

SAT0151 Long-term safety of 4-weekly certolizumab pegol in rheumatoid arthritis: 5 year results from an open label extension study:

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 523.1-523 ◽  
Author(s):  
R. Fleischmann ◽  
R. van Vollenhoven ◽  
J. Vencovsky ◽  
R. Alten ◽  
O. Davies ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Certolizumab Pegol ◽  
Extension Study ◽  
Open Label ◽  
Open Label Extension
Sign in / Sign up

Export Citation Format

Share Document